Factors associated with pregnancy outcome in anti‐TNF treated women with inflammatory bowel disease
Medienart: |
Artikel |
---|
Erscheinungsjahr: |
2014 |
---|---|
Erschienen: |
2014 |
Enthalten in: |
Zur Gesamtaufnahme - volume:40 |
---|---|
Enthalten in: |
Alimentary pharmacology & therapeutics - 40(2014), 4 vom: Aug., Seite 363-373 |
Beteiligte Personen: |
Seirafi, M. [VerfasserIn] |
---|
BKL: |
---|
Umfang: |
11 |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
OLC1947209558 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | OLC1947209558 | ||
003 | DE-627 | ||
005 | 20230518185329.0 | ||
007 | tu | ||
008 | 140718s2014 xx ||||| 00| ||und c | ||
028 | 5 | 2 | |a sw140717_1 |
035 | |a (DE-627)OLC1947209558 | ||
035 | |a (DE-599)GBVOLC1947209558 | ||
035 | |a (KEY)0157873120140800040000400363factorsassociatedwithpregnancyoutcomeinantitnftrea | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
082 | 0 | 4 | |a 610 |
084 | |a 44.87 |2 bkl | ||
084 | |a 44.38 |2 bkl | ||
100 | 1 | |a Seirafi, M. |e verfasserin |4 aut | |
245 | 1 | 0 | |a Factors associated with pregnancy outcome in anti‐TNF treated women with inflammatory bowel disease |
264 | 1 | |c 2014 | |
300 | |a 11 | ||
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
338 | |a Band |b nc |2 rdacarrier | ||
700 | 1 | |a Vroey, B. |4 oth | |
700 | 1 | |a Amiot, A. |4 oth | |
700 | 1 | |a Seksik, P. |4 oth | |
700 | 1 | |a Roblin, X. |4 oth | |
700 | 1 | |a Allez, M. |4 oth | |
700 | 1 | |a Peyrin‐Biroulet, L. |4 oth | |
700 | 1 | |a Marteau, P. |4 oth | |
700 | 1 | |a Cadiot, G. |4 oth | |
700 | 1 | |a Laharie, D. |4 oth | |
700 | 1 | |a Boureille, A. |4 oth | |
700 | 1 | |a De Vos, M. |4 oth | |
700 | 1 | |a Savoye, G. |4 oth | |
700 | 1 | |a Rahier, J.‐F. |4 oth | |
700 | 1 | |a Carbonnel, F. |4 oth | |
700 | 1 | |a Bonaz, B. |4 oth | |
700 | 1 | |a Colombel, J.‐F. |4 oth | |
700 | 1 | |a Bouhnik, Y. |4 oth | |
773 | 0 | 8 | |i Enthalten in |t Alimentary pharmacology & therapeutics |d Oxford : Wiley-Blackwell, 1987 |g 40(2014), 4 vom: Aug., Seite 363-373 |w (DE-627)130433233 |w (DE-600)639012-2 |w (DE-576)028460936 |x 0269-2813 |7 nnns |
773 | 1 | 8 | |g volume:40 |g year:2014 |g number:4 |g month:08 |g pages:363-373 |g extent:11 |
912 | |a GBV_USEFLAG_A | ||
912 | |a SYSFLAG_A | ||
912 | |a GBV_OLC | ||
912 | |a SSG-OLC-PHA | ||
912 | |a SSG-OLC-DE-84 | ||
912 | |a GBV_ILN_4012 | ||
912 | |a GBV_ILN_4219 | ||
936 | b | k | |a 44.87 |q AVZ |
936 | b | k | |a 44.38 |q AVZ |
951 | |a AR | ||
952 | |d 40 |j 2014 |e 4 |c 8 |h 363-373 |g 11 |